• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

Recent Advances in the Application of 3-(1-Pyrrolidinyl)benzaldehyde (CAS: 857283-89-7) in Chemical Biology and Pharmaceutical Research

3-(1-Pyrrolidinyl)benzaldehyde (CAS: 857283-89-7) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its pyrrolidine-substituted benzaldehyde structure, serves as a key building block in the synthesis of various bioactive molecules. Recent studies have explored its utility in drug discovery, particularly in the development of novel therapeutic agents targeting neurological disorders, cancer, and infectious diseases.

One of the most notable advancements involving 3-(1-Pyrrolidinyl)benzaldehyde is its role in the synthesis of small-molecule inhibitors for protein-protein interactions (PPIs). PPIs are often considered challenging targets due to their large and flat interfaces, but recent research has demonstrated that derivatives of 3-(1-Pyrrolidinyl)benzaldehyde can effectively modulate these interactions. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the development of a series of PPI inhibitors derived from this compound, which showed promising activity against cancer-related targets such as MDM2-p53.

In addition to its applications in PPI modulation, 3-(1-Pyrrolidinyl)benzaldehyde has also been investigated as a precursor for the synthesis of fluorescent probes. These probes are valuable tools for studying biological processes in real-time, enabling researchers to visualize and quantify molecular events within living cells. A recent study in ACS Chemical Biology highlighted the use of this compound in the development of a novel fluorescent probe for detecting reactive oxygen species (ROS) in neuronal cells, providing insights into oxidative stress-related pathologies.

Another area of interest is the compound's potential in the design of covalent inhibitors. Covalent inhibitors, which form irreversible or reversible bonds with their target proteins, have gained traction in drug discovery due to their high potency and selectivity. Researchers have utilized 3-(1-Pyrrolidinyl)benzaldehyde as a scaffold to design covalent inhibitors for enzymes such as kinases and proteases. A 2022 publication in Nature Chemical Biology described the successful application of this strategy in developing inhibitors for Bruton's tyrosine kinase (BTK), a key target in B-cell malignancies.

Despite these promising developments, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of 3-(1-Pyrrolidinyl)benzaldehyde-derived compounds. Issues such as poor solubility, metabolic instability, and off-target effects need to be addressed to fully realize their therapeutic potential. Recent efforts have focused on structural modifications and formulation strategies to overcome these limitations, as evidenced by a 2023 study in European Journal of Medicinal Chemistry that reported improved bioavailability of a derivative through prodrug design.

In conclusion, 3-(1-Pyrrolidinyl)benzaldehyde (CAS: 857283-89-7) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its potential to yield bioactive molecules, makes it a compound of significant interest. Future research will likely explore its applications in emerging areas such as targeted protein degradation and immunotherapy, further expanding its impact on drug discovery and development.

• 1079-83-0(4-[butyl(methyl)amino]benzaldehyde)
• 613-28-5(4-(Dipropylamino)benzaldehyde)
• 90134-10-4(4-(Dibutylamino)benzaldehyde)
• 922528-43-6(2-Naphthalenecarboxaldehyde, 6-(1-pyrrolidinyl)-)
• 10338-57-5(4-(piperidin-1-yl)benzaldehyde)
• 90133-80-5(Benzaldehyde, 4-(dihexylamino)-)
• 111462-11-4(Benzaldehyde, 4,4'-[1,4-butanediylbis(butylimino)]bis-)
• 84754-31-4(2-Methyl-4-pyrrolidin-1-ylbenzaldehyde)
• 669050-72-0(3-(piperidin-1-yl)benzaldehyde)
• 51980-54-2(4-(Pyrrolidin-1-yl)benzaldehyde)